| Literature DB >> 10600093 |
B C Lund1, R F Neiman, P J Perry.
Abstract
Pergolide is a dopaminergic agonist used to treat Parkinson's disease but is associated with the development of retroperitoneal fibrosis (RPF). Newer nonergot agents (pramipexole, ropinirole) may not carry this same risk. A patient with a history of pergolide-induced RPF was treated successfully with ropinirole for 1 year without complications.Entities:
Mesh：
Substances：
Year: 1999 PMID： 10600093 DOI： 10.1592/phco.19.18.1437.30888
Source DB: PubMed Journal: Pharmacotherapy ISSN： 0277-0008 Impact factor: 4.705